1.Elucidation of the binding mechanism of astragaloside IV derivative with human serum albumin and its cardiotoxicity in zebrafish embryos

Wu, YJ, Li, ZH, Li,     More...

Wu, YJ, Li, ZH, Li, JY, Zhou, Y, Wang, RY, Chen, XY, Qing, LS, Luo, P     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2022, Volume 13,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  5.6  发表年影響因子:  5.6 

2.Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1Ser616 Phosphorylation-Mediated Mitochondrial Fission

Chen, Li, Chen, Xiao     More...

Chen, Li, Chen, XiaoYi, Wang, QianLong, Zhou, Hua, Luo, Pei, Yang, SiJin, Ding, LiSheng, Qing, LinSen     Less

Frontiers in Pharmacology[1663-9812], Published 2020, Volume 11,

收錄情况： WOS SCOPUS

WOS核心合集引用: 26  2022影響因子:  5.6  发表年影響因子:  5.811 

3.Identification of Active Compounds From Yi Nationality Herbal Formula Wosi Influencing COX-2 and VCAM-1 Signaling

Zhang, JiZhong, Liu,     More...

Zhang, JiZhong, Liu, Yuan, Chen, XiaoYi, Wu, YouJiao, Luo, Pei, Li, LiMin, Huang, Li, Yin, QiaoZhi     Less

Frontiers in Pharmacology[1663-9812], Published 2020, Volume 11,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2022影響因子:  5.6  发表年影響因子:  5.811 

4.Activation of Nrf2/HO-1 Pathway by Nardochinoid C Inhibits Inflammation and Oxidative Stress in Lipopolysaccharide-Stimulated Macrophages

Luo, JF, Shen, XY, L     More...

Luo, JF, Shen, XY, Lio, CK, Dai, Y, Cheng, CS, Liu, JX, Yao, YD, Yu, Y, Xie, Y, Luo, P, Yao, XS, Liu, ZQ, Zhou, H     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2018, Volume 9, Issue SEP,

收錄情况： WOS SCOPUS

WOS核心合集引用: 118  2022影響因子:  5.6  发表年影響因子:  3.845